Trial: 201909014

NRG-LU005, Limited Stage Small Cell Lung Cancer (LS-SCLC): A Phase II/II Randomized Study of Chemoradiation versus Chemoradiation plus atezolizumab

Phase

II/III

Principal Investigator

Robinson, Clifford

Disease Site

Lung; Lung Cancer – Small Cell

Learn more about this study at: clinicaltrials.gov